The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration

Chiara Cencioni, Silvia Malatesta, Virginia Vigiano Benedetti, Valerio Licursi, Livia Perfetto, Federica Conte, Danilo Ranieri, Armando Bartolazzi, Martina Kunkl, Loretta Tuosto, Alberto Larghi, Geny Piro, Antonio Agostini, Giampaolo Tortora, Vincenzo Corbo, Carmine Carbone, Francesco Spallotta

Open source

DOI: 10.1186/s13046-024-03263-w
Published: 2025-01-20
Container: Journal of Experimental & Clinical Cancer Research
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13046-024-03263-w,
  title = {The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration},
  author = {Chiara Cencioni and Silvia Malatesta and Virginia Vigiano Benedetti and Valerio Licursi and Livia Perfetto and Federica Conte and Danilo Ranieri and Armando Bartolazzi and Martina Kunkl and Loretta Tuosto and Alberto Larghi and Geny Piro and Antonio Agostini and Giampaolo Tortora and Vincenzo Corbo and Carmine Carbone and Francesco Spallotta},
  year = {2025},
  journal = {Journal of Experimental \&amp; Clinical Cancer Research},
  doi = {10.1186/s13046-024-03263-w},
  url = {https://doi.org/10.1186/s13046-024-03263-w}
}

RIS

TY  - JOUR
TI  - The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration
AU  - Chiara Cencioni
AU  - Silvia Malatesta
AU  - Virginia Vigiano Benedetti
AU  - Valerio Licursi
AU  - Livia Perfetto
AU  - Federica Conte
AU  - Danilo Ranieri
AU  - Armando Bartolazzi
AU  - Martina Kunkl
AU  - Loretta Tuosto
AU  - Alberto Larghi
AU  - Geny Piro
AU  - Antonio Agostini
AU  - Giampaolo Tortora
AU  - Vincenzo Corbo
AU  - Carmine Carbone
AU  - Francesco Spallotta
PY  - 2025
JO  - Journal of Experimental &amp; Clinical Cancer Research
DO  - 10.1186/s13046-024-03263-w
UR  - https://doi.org/10.1186/s13046-024-03263-w
ER  -

APA

Cencioni, C., Malatesta, S., Benedetti, V. V., Licursi, V., Perfetto, L., Conte, F., Ranieri, D., Bartolazzi, A., Kunkl, M., Tuosto, L., Larghi, A., Piro, G., Agostini, A., Tortora, G., Corbo, V., Carbone, C., & Spallotta, F. (2025). The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-024-03263-w

Source records

crossref · retrieved 2026-09-26T15:15:40.508Z